(PNR) Pentair - Overview
Stock: Pumps, Filters, Heaters, Controls, Valves
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.03% |
| Yield on Cost 5y | 1.94% |
| Yield CAGR 5y | 5.74% |
| Payout Consistency | 97.0% |
| Payout Ratio | 23.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 51.9% |
| Relative Tail Risk | -2.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.00 |
| Alpha | -17.38 |
| Character TTM | |
|---|---|
| Beta | 1.120 |
| Beta Downside | 0.988 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.09% |
| CAGR/Max DD | 0.75 |
Description: PNR Pentair December 19, 2025
Pentair plc (NYSE:PNR) is a global provider of water-related products and services, operating in the United States, Western Europe, China, and other key regions. The business is organized into three segments: Flow (industrial pumps and fluid-treatment systems), Water Solutions (residential/commercial water-treatment hardware and services), and Pool (residential and commercial pool equipment and aquaculture solutions). The company’s brand portfolio includes Pentair, Aurora, Everpure, Kreepy Krauly, and Sta-Rite, among others.
In FY 2023 Pentair reported revenue of roughly $3.1 billion, with the Flow segment contributing about 55 % of sales and delivering an adjusted EBITDA margin near 13 %. The Water Solutions segment, which benefits from rising demand for water-reuse and softening technologies, grew at a 7 % annual rate, while the Pool segment remained cyclical, expanding modestly as residential construction rebounded.
Key macro drivers for Pentair include the U.S. $55 billion water-infrastructure investment plan, tightening water-quality regulations in Europe and China, and the broader trend toward water-conservation and reuse in agriculture and industry. Conversely, the pool business is sensitive to discretionary-spending cycles and weather patterns, which adds volatility to that segment’s outlook.
Investors looking for a deeper, data-driven breakdown of Pentair’s valuation metrics and scenario analysis may find the free tools on ValueRay useful for independent research.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 653.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 0.18 > 1.0 |
| NWC/Revenue: 13.95% < 20% (prev 13.25%; Δ 0.70% < -1%) |
| CFO/TA 0.12 > 3% & CFO 819.1m > Net Income 653.8m |
| Net Debt (1.54b) to EBITDA (943.6m): 1.63 < 3 |
| Current Ratio: 1.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (164.7m) vs 12m ago -1.44% < -2% |
| Gross Margin: 40.48% > 18% (prev 0.39%; Δ 4008 % > 0.5%) |
| Asset Turnover: 62.72% > 50% (prev 63.33%; Δ -0.61% > 0%) |
| Interest Coverage Ratio: 11.90 > 6 (EBITDA TTM 943.6m / Interest Expense TTM 69.4m) |
Altman Z'' 4.03
| A: 0.08 (Total Current Assets 1.54b - Total Current Liabilities 959.3m) / Total Assets 6.87b |
| B: 0.39 (Retained Earnings 2.70b / Total Assets 6.87b) |
| C: 0.12 (EBIT TTM 825.9m / Avg Total Assets 6.66b) |
| D: 1.29 (Book Value of Equity 3.87b / Total Liabilities 3.00b) |
| Altman-Z'' Score: 4.03 = AA |
Beneish M -2.99
| DSRI: 1.08 (Receivables 673.2m/611.9m, Revenue 4.18b/4.08b) |
| GMI: 0.97 (GM 40.48% / 39.16%) |
| AQI: 1.02 (AQ_t 0.72 / AQ_t-1 0.70) |
| SGI: 1.02 (Revenue 4.18b / 4.08b) |
| TATA: -0.02 (NI 653.8m - CFO 819.1m) / TA 6.87b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of PNR shares?
Over the past week, the price has changed by -7.73%, over one month by -5.30%, over three months by -10.21% and over the past year by -0.08%.
Is PNR a buy, sell or hold?
- StrongBuy: 11
- Buy: 4
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PNR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 113.7 | 16.8% |
| Analysts Target Price | 113.7 | 16.8% |
| ValueRay Target Price | 111.5 | 14.5% |
PNR Fundamental Data Overview February 08, 2026
P/E Forward = 18.0505
P/S = 3.8215
P/B = 4.1143
P/EG = 1.4569
Revenue TTM = 4.18b USD
EBIT TTM = 825.9m USD
EBITDA TTM = 943.6m USD
Long Term Debt = 1.64b USD (from longTermDebt, last quarter)
Short Term Debt = 26.1m USD (from shortTermDebt, two quarters ago)
Debt = 1.64b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.54b USD (from netDebt column, last quarter)
Enterprise Value = 17.50b USD (15.96b + Debt 1.64b - CCE 101.6m)
Interest Coverage Ratio = 11.90 (Ebit TTM 825.9m / Interest Expense TTM 69.4m)
EV/FCF = 23.32x (Enterprise Value 17.50b / FCF TTM 750.3m)
FCF Yield = 4.29% (FCF TTM 750.3m / Enterprise Value 17.50b)
FCF Margin = 17.97% (FCF TTM 750.3m / Revenue TTM 4.18b)
Net Margin = 15.66% (Net Income TTM 653.8m / Revenue TTM 4.18b)
Gross Margin = 40.48% ((Revenue TTM 4.18b - Cost of Revenue TTM 2.49b) / Revenue TTM)
Gross Margin QoQ = 40.35% (prev 40.96%)
Tobins Q-Ratio = 2.55 (Enterprise Value 17.50b / Total Assets 6.87b)
Interest Expense / Debt = 1.06% (Interest Expense 17.4m / Debt 1.64b)
Taxrate = 12.26% (22.6m / 184.4m)
NOPAT = 724.7m (EBIT 825.9m * (1 - 12.26%))
Current Ratio = 1.61 (Total Current Assets 1.54b / Total Current Liabilities 959.3m)
Debt / Equity = 0.42 (Debt 1.64b / totalStockholderEquity, last quarter 3.87b)
Debt / EBITDA = 1.63 (Net Debt 1.54b / EBITDA 943.6m)
Debt / FCF = 2.05 (Net Debt 1.54b / FCF TTM 750.3m)
Total Stockholder Equity = 3.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.82% (Net Income 653.8m / Total Assets 6.87b)
RoE = 17.48% (Net Income TTM 653.8m / Total Stockholder Equity 3.74b)
RoCE = 15.36% (EBIT 825.9m / Capital Employed (Equity 3.74b + L.T.Debt 1.64b))
RoIC = 13.67% (NOPAT 724.7m / Invested Capital 5.30b)
WACC = 9.19% (E(15.96b)/V(17.60b) * Re(10.04%) + D(1.64b)/V(17.60b) * Rd(1.06%) * (1-Tc(0.12)))
Discount Rate = 10.04% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.60%
[DCF Debug] Terminal Value 77.49% ; FCFF base≈727.1m ; Y1≈896.9m ; Y5≈1.53b
Fair Price DCF = 117.5 (EV 20.77b - Net Debt 1.54b = Equity 19.23b / Shares 163.6m; r=9.19% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 62.07 | EPS CAGR: 9.14% | SUE: 0.13 | # QB: 0
Revenue Correlation: 0.07 | Revenue CAGR: 0.55% | SUE: 1.83 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.17 | Chg30d=-0.070 | Revisions Net=-5 | Analysts=17
EPS current Year (2026-12-31): EPS=5.34 | Chg30d=-0.043 | Revisions Net=-5 | Growth EPS=+8.5% | Growth Revenue=+3.2%
EPS next Year (2027-12-31): EPS=5.81 | Chg30d=-0.049 | Revisions Net=-3 | Growth EPS=+8.9% | Growth Revenue=+4.7%